The market investigation also highlighted concerns regarding reduction of choice.
In particular, market participants were concerned that as a result of the merger, veterinary clinics owned by Mars would be obliged to sells Mars' brand of dietetic food (Royal Canin) and that this could lead to a reduction in choice for the customer. For example, one competitor noted: "We do expect the acquisition to impact our business. Obviously all clinics will carry the RC [Royal Canin] brand as preferred/recommended brand. And since RC has by far the largest number of SKUs141 of any therapeutic pet food company – this will effect and influence space management and limit competitors opportunities and restrict their number.
Few clinics have the space and capacity to handle more than 3 brands."142